Article Details

Xtandi Approved for Nonmetastatic Castration-Sensitive Prostate Cancer

Retrieved on: 2023-11-21 16:07:11

Tags for this article:

Click the tags to see associated articles and topics

Xtandi Approved for Nonmetastatic Castration-Sensitive Prostate Cancer. View article details on hiswai:

Excerpt

Pfizer and Astellas' Xtandi® approved by US FDA in earlier prostate cancer treatment setting. News release. Pfizer and Astellas Pharma. November ...

Article found on: www.cancertherapyadvisor.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up